Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_4518_Библиотеки_им_академика_М_И_Перельмана
.pdf
354
https://t.me/medicina_free
Z. G. Schwam and M. Khan
– Oncocytoma: Oncocytes refer to cells with excessive mitochondria, with aci-
dophilic, granular cytoplasm. Associated with aging.
– Hemangioma: Most common lesion of childhood. Similar growth and involu-
tion patterns as other hemangiomas.
– Kuttner tumor (chronic sclerosing sialadenitis): heavy lymphoid inltrate in
the submandibular gland that can mimic a mass.
– Benign lymphoepithelial cyst (BLEC): benign cystic parotid lesions that may
be bilateral and found almost exclusively in patients with HIV. Treatment
consists of anti-retroviral therapy and sclerotherapy.
– Mucocele: frequently found on the lower lip as a result of trauma.
– Myoepithelioma
– Basal cell adenoma: may mimic adenoid cystic carcinoma
– Canalicular adenoma: frequently found on the upper lip.
– Sialadenosis: hypertrophic acinar cells. May be secondary to endocrinopathy,
alcohol dependence, malnutrition, or anti-cholinergics.
• Malignant lesions
– AJCC 8th edition staging (AJCC):
T1: 0–2cm, T2: 2–4cm, T3: >4cm or with extraparenchymal extension,
T4a: gross invasion of the skin, mandible, facial nerve, or external ear
canal. T4b: invades the skullbase, pterygoids, or encases carotid.
– Indications for neck dissection and radiation
Neck dissection is indicated for high-grade neoplasms and for those
patients with clinically evident cervical lymphadenopathy. Elective neck
dissection may be considered in those with T3/T4 tumors or extraparenchymal extension.
Adjuvant radiation in the event of close/+ margins, extraparenchymal
extension, perineural invasion, high-grade or recurrent low-grade lesion,
lymphadenopathy.
– Mucoepidermoid carcinoma: most common malignant salivary lesion in both
adults and children. Low-grade tumors have glandular and microcystic fea-
tures that may be associated with a t(11;19) translocation. Higher grade
lesions associated with lymphadenopathy and a larger epithelial component
on histology.
– Adenoid cystic carcinoma: Second most common malignant salivary lesions.
Characterized by perineural invasion with delayed distant mets. Nearly all
patients get adjuvant radiation.
Cribriform (Swiss cheese appearance, most common), tubular (low grade,
best prognosis), solid (high grade, worst prognosis)
– Acinic cell carcinoma: predominantly low-grade neoplasm.
– Epithelial-myoepithelial: locoregionally aggressive but with relatively low
mortality.

18 Salivary Gland Diseases
https://t.me/medicina_free
– Salivary ductal carcinoma: high grade, very aggressive, early locoregional
mets, need adjuvant radiation.
– Adenocarcinoma: high-grade lesion, most commonly in minor salivary glands.
– Polymorphous low-grade adenocarcinoma: may have perineural invasion.
More common in minor salivary glands. Rare neck mets.
– Carcinoma ex-pleomorphic adenoma: rapid growth in a long-standing lesion.
Poor overall survival. Adjuvant radiation common.
– Lymphoma. May have nodal (non-Hodgkin lymphoma) or MALT lymphoma.
Sjogren disease patients at higher lymphoma risk.
– Metastases: SCC > melanoma. BCC may invade directly. SCC > 2 cm or
>4mm thick or those located preauricular have increased incidence of mets to
parotid.
• Post-surgical complications
– Sialocele
– Frey syndrome: gustatory sweating. From re-routing of postganglionic para-
sympathetics from the parotid to the sweat glands.
– Facial palsy
– Auricular numbness: from damage or transection of the great auricular nerve.
Further Reading
355
1. Baker EW, Michael S, Schulte E, Schumacher U.Head and neck anatomy for dental medicine.
NewYork: Thieme; 2010.
2. Amin MB, Edge SB, editors. American Joint Committee on Cancer Cancer staging manual.
8th ed. Berlin: Springer; 2017.
3. Bastakis JG, Regezi JA.The pathology of head and neck tumors: salivary glands, Part 1. Head
Neck Surg. 1978;1:59.
4. Bastakis JG, Regezi JA, Repola DA.The pathology of head and neck tumors: salivary glands,
Part 2. Head Neck Surg. 1978;1:167.
5. Bradley PJ, Eisele DW, editors. Salivary gland neoplasms. Basel: Karger; 2016.
6. Brandwein MS, Ferlito A, Bradley PJ, Hille JJ, Rinaldo A.Diagnosis and classication of salivary neoplasms: pathologic challenges and relevance to clinical outcomes. Acta Otolaryngol.
2002;122:758–64.
7. Califano J, Eisele DW. Benign salivary gland neoplasms. Otolaryngol Clin N Am.
1999;32:861–73.
8. Chan Y, Goddard JC, editors. K.J.Lee’s essential otolaryngology: head & neck surgery. 11th
ed. NewYork: McGraw-Hill Education; 2016.
9. Colevas AD, Yom SS, Pster DG, etal. NCCN guidelines insights: head and neck cancers,
version 1.2018. J Natl Compr Cancer Netw. 2018;16:479–90.
10. Edgar WM.Saliva: its secretion, composition and functions. Br Dent J. 1992;172:305.
11. Eveson JW, Cawson RA.Salivary gland tumors. A review of 2410 cases with particular reference to histological types, site, age, and sex distribution. J Pathol. 1985;146:51.
12. Flint PW, Haughey BH, Lund VJ, etal., editors. Cummings otolaryngology: head and neck
surgery. 6th ed. Elsevier/Saunders: Philadelphia, PA; 2015.
13. Frable MA, Frable WJ. Fine-needle aspiration biopsy of salivary glands. Laryngoscope.
1991;101:245–9.

356
https://t.me/medicina_free
14. Hiatt JL, Gartner LP.Textbook of head and neck anatomy. 4th ed. Philadelphia, PA: Wolters
Kluwer Health/Lippincott William & Wilkins; 2010.
15. Johnson JT, Rosen CA, editors. Bailey’s head and neck surgery: otolaryngology. 5th ed.
Wolters Kluwer Health/Lippincott Williams & Wilkins: Philadelphia, PA; 2014.
16. McQuone SJ.Acute viral and bacterial infections of the salivary glands. Otolaryngol Clin N
Am. 1999;32:793.
17. Myers EN, Snyderman CH, editors. Operative otolaryngology: head and neck surgery. 3rd ed.
Philadelphia, PA: Elsevier; 2018.
18. Som PM, Curtin HD.Head and neck imaging. 5th ed. St. Louis: Mosby Elsevier; 2011.
19. Spiro RH.Salivary neoplasms: overview of a 35-year experience with 2,807 patients. Head
Neck Surg. 1986;8:177–84.
20. Turner MD, Troulis MJ.Sialendoscopy and minimally invasive salivary gland surgery. Atlas
Oral Maxillofac Surg Clin North Am. 2018;26:i.
21. Turner MD.Combined surgical approaches for the removal of submandibular gland sialoliths.
Atlas Oral Maxillofac Surg Clin North Am. 2018;26:145–51.
22. Westra WH.The surgical pathology of salivary gland neoplasms. Otolaryngol Clin N Am.
1999;32:919.
Z. G. Schwam and M. Khan

Chapter 19
https://t.me/medicina_free
Head andNeck Lymphoma andSarcoma
VivianF.Kaul, MohemmedKhan, andBrettA.Miles
Pearls
• The treatment of lymphoma is quite complex (multimodal) and requires accurate
diagnosis including open lymph node biopsy with ow cytometry analysis and
architecture
• Unfavorable sarcoma histology—angiosarcomas, rhabdomyosarcomas espe-
cially of the alveolar morphological type, and osteosarcomas are devastatingly
aggressive tumors with an extremely high incidence of distant metastasis
• Malignant brous histiocytoma is the most common soft tissue sarcoma in adults
• Rhabdomyosarcoma—embryonal subtype if found in the orbit has the most
favorable outcome
• Angiosarcoma is an aggressive vascular malignancy that often presents in the
cutaneous scalp of older Caucasian males; prognosis is poor
• Liposarcoma, if metastasizes, uniquely has a propensity for bone
• Synovial sarcoma is primarily a surgical disease
• Dermatobrosarcoma protuberans is a low-grade tumor with a predilection for
local recurrence
• Ewings sarcoma is associated with a mutation in the EWS gene, classically iden-
tied as a small blue round tumor
V. F. Kaul (*) · M. Khan
Department of Otolaryngology - Head and Neck Surgery, Icahn School of Medicine at the
Mount Sinai Hospital, New York, NY, USA
e-mail: Vivian.zhu@mountsinai.org; mohemmed.khan@mountsinai.org
B. A. Miles
Otolaryngology Head and Neck Surgery, Oral and Maxillofacial Surgery, Northwell Health
System, New Hyde Park, NY, USA
e-mail: bmiles4@northwell.edu
© Springer Nature Switzerland AG 2023
F. Y. Lin, Z. M. Patel (eds.), ENT Board Prep,
https://doi.org/10.1007/978-3-031-26048-3_19
357

358
https://t.me/medicina_free
V. F. Kaul et al.
• Osteosarcoma is the most common malignancy of the bone, majority of which
are high grade
• Chondrosarcoma may present as a slowly expanding mass of the laryngeal or the
cricoid cartilages; treatment is surgical resection
• Radiation-induced sarcoma must occur after median latent period of 9–12years
Lymphoma
Epidemiology
• Lymphoma can also be nodal or extranodal (most common site as Waldeyer’s
ring—base of tongue, tonsils, and adenoids)
• Waldeyer’s ring is extranodal; however, in the staging, it is considered as nodal
location
• Hodgkin lymphoma (HL) or non-Hodgkin lymphoma (NHL)—B or T cell
(Table19.1)
Table 19.1 World Health Organization lymphoma classication
Lineage B cell T cell Hodgkin
Types
Precursor lymphoblastic
leukemia
Chronic lymphocytic
leukemia-small lymphocytic
Prolymphocytic Large granular lymphocytic Lymphocyte-rich
Lymphoplasmacytic Aggressive NK-cell Mixed cellularity
Splenic marginal zone Adult T-cell—leukemia Lymphocyte
Hairy cell leukemia Extranodal NK-T-cell-nasal type
Plasma cell myeloma/
plasmacytoma
Extranodal marginal zone of
MALT type
Follicular Subcutaneous panniculitis-like
Mantle cell Mycosis fungoides—Sezary
Diffuse large Anaplastic large cell, T/null
Mediastinal large Peripheral T-cell—not otherwise
Primary effusion Angioimmunoblastic
Burkitt variants Anaplastic large cell, Y/null
Precursor lymphoblastic
leukemia
Prolymphocytic Nodular sclerosis
Enteropathic
Hepatosplenic
syndrome
cell—primary cutaneous type
characterized
cell—primary systemic type
Nodular
lymphocytic
predominance
classical
depleted

19 Head andNeck Lymphoma andSarcoma
https://t.me/medicina_free
• 25% extranodal lymphomas occur in the head and neck, and 8% of ndings on
supraclavicular ne-needle aspirate biopsy yield a diagnosis of lymphoma
• Typically present as one or more slowly enlarging rubbery lymph nodes in
the neck
• Chromosomal abnormalities
– Aneuploidy occurs in HL
– Translocations and deletions in NHL (c-myc translocation of Burkitt lym-
phoma and the bcl-2 translocation in follicular lymphomas)
• Infectious agents implicated
– Epstein–Barr virus
– HIV-1
– Helicobacter pylori
– Human T-cell lymphotropic virus-1 (HTLV-1)
– Hepatitis B and C viruses
– Human herpes virus 8
– Borrelia burgdorferi
– Chlamydia psittaci
– Campylobacter jejuni
• Chronic inammation increases the risk of lymphoma, i.e., MALT lymphoma
and Sjögren’s syndrome
• Hashimoto disease increases a patient’s risk of thyroid lymphoma approximately
70×, usually aggressive NHL
• Immunosuppression following organ transplantation increases the risk of lym-
phoma and may regress after cessation of immune suppression (EBVassociated NHL)
• HIV infection signicantly increases the incidence of lymphoma. The risk is
increased approximately 1000-fold for Burkitt lymphoma and 400-fold for
aggressive lymphoma
359
Hodgkin Lymphoma
• Extends by means of contiguous nodal spread; therefore, it is often localized and
frequently occurs in the mediastinum
• Incidence of HL is increased tenfold in same-sex siblings
Non-Hodgkin Lymphoma
• Tends to spread hematogenously and is often systemic at diagnosis
• NHL may present as a mass in the oropharynx or nasopharynx (Waldeyer’s ring)
or parotid

360
https://t.me/medicina_free
• Primary lymphoma of the oral cavity usually arises in the tongue base and is
rarer than a cervical presentation
• Lymphoma masses tend to be rubbery, rm, and non-ulcerating
• Worse prognosis relative to HL
V. F. Kaul et al.
Extranodal NK/T-Cell Lymphoma
• Aggressive ulcerative destructive locally invasive lesion of the nose, sinuses,
and face
• Associated with Epstein–Barr virus and worse prognosis compared with that of
patients with B-cell lymphoma
• Presents as a nasal mass, epistaxis, and/or nasal obstruction and pain
• More common in male adults, Asian and Native Americans
• Poor prognosis, 5-year survival of 50%
Burkitt Lymphoma
• Endemic (African form) manifests as a jaw or an abdominal tumor that spreads
to extranodal sites
• Nonendemic (North American form) has an abdominal presentation with mas-
sive disease
Imaging
• Standard protocol is CT scanning of the chest, abdomen, and/or pelvis
• CT/MRI often indicated for head and neck lymphoma for accurate staging
and therapy
• Positron emission tomography (PET) scanning indicated for staging of disease,
detection of recurrence, and monitoring treatment response
Evaluation andHistology
• Initial evaluation is generally ne-needle aspiration cytology to differentiate
from other malignancies
• Biopsy should be considered when a rm lymph node is larger than 1cm and is
not associated with infection and persists longer than 4weeks

19 Head andNeck Lymphoma andSarcoma
https://t.me/medicina_free
• May also have painless or mildly tender peripheral adenopathy in cervical, axil-
lary, inguinal, and femoral regions
• Flow cytometry may be utilized for preliminary classication; however, often
excisional lymph node biopsy is warranted for architecture for HL and NHL,
submitted fresh for analysis
• CD20 is present in all B-cell lymphomas, an essential marker for
immunotherapy
• CD10 expression is more frequently seen in follicular type of well-differentiated
non-Hodgkin lymphoma
• Bcl-2 is a poor prognosis marker whereas Bcl-6 is a favorable marker for
prognosis
• Immunohistochemical analysis identies monoclonal antibody targets such as
CD20 (rituximab) or CD52 (alemtuzumab)
• Diffuse large B-cell lymphoma, uorescent in situ hybridization (FISH) for
t(8;14)/MYC translocation which is associated with a poor prognosis
• Bone marrow aspiration and lumbar puncture are also frequently indicated to
detect disseminated disease in the bone marrow or CSF via ow cytometry
• Diagnostic tonsillectomy may be indicated if lymphoma of the tonsils is sus-
pected in the setting of tonsillar asymmetry
361
Staging
Hodgkin and non-Hodgkin lymphoma new Lugano staging system (2017)
Stage I—Involvement of a single lymph node region or lymphoid structure or it
is found in only one area of single organ outside the lymph system
Stage II—Involvement of two or more lymph node regions on the same side of
the diaphragm or localized contiguous involvement of only one extra-lymphatic site
and lymph node region.
Stage III—Involvement of lymph node regions or lymphoid structures on both
sides of the diaphragm or lymph nodes involved above the diaphragm and the spleen.
Stage IV—Disseminated involvement of one or more extra-lymphatic organs
Letter Designations
A—Asymptomatic.
B—Constitutional symptoms: Persistent or recurrent fever with temperature
higher than 38°C or by recurrent and drenching night sweats within 1month, or by
unexplained loss of more than 10% of the person’s body weight within 6months.
E—Extranodal: Direct extension into extra-lymphatic organ from an adjacent
lymph node.

362
https://t.me/medicina_free
X—Bulky disease: Width of the mediastinal tumor is greater than one-third of
the transthoracic diameter at T5/6, or the diameter of the tumor diameter is larger
than 10cm.
V. F. Kaul et al.
Management
• Generally treated with chemotherapy±radiotherapy
• Occasionally with early local disease radiotherapy alone may be an option
• Radiotherapy is the primary treatment modality in early-stage NK/T-cell
lymphomas
Hodgkin Lymphoma
• ABVD is a regimen of doxorubicin (Adriamycin), bleomycin, vinblastine, and
dacarbazine now considered the standard of care in HL (70% event-free survival
in favorable stages)
• BEACOPP (i.e., cyclophosphamide, doxorubicin, etoposide, procarbazine, pred-
nisolone, vincristine, and bleomycin with granulocyte colony-stimulating factor)
are being used for advanced HL
• Stanford V regimen (mechlorethamine, doxorubicin, vinblastine, vincristine,
bleomycin, etoposide, and prednisone) with consolidative radiotherapy to bulky
sites produces a progression-free survival of over 74%
• Modied CHOP—including pirarubicin, cyclophosphamide, vincristine and
prednisone (THP-COP) plus radiotherapy for early-stage aggressive non-
Hodgkin’s lymphoma of the head and neck has shown 5-year survival
rates of 89%
Non-Hodgkin Lymphoma
Indolent B-Cell Lymphoma
• Multiple subtypes are generally considered incurable with conven-
tional therapy
• Characterized by an indolent course, patients may remain stable for several years
without therapy
• Watch-and-wait strategy is often used
• Chemotherapy for symptomatic disease, hypersplenism, or bone marrow inltra-
tion causing cytopenia

19 Head andNeck Lymphoma andSarcoma
https://t.me/medicina_free
363
Aggressive B-Cell Lymphomas
• These include diffuse large BCL (most common type of non-Hodgkin lymphoma
of head and neck, Burkitt lymphoma), mantle-cell lymphoma, and lymphoblastic
lymphoma
• Potentially curable
– Chemotherapy and consolidation radiotherapy have 5-year survival rates of
up to 80% depending on stage
– Newer immunochemotherapy regimens (i.e., rituximab (DA-EPOCH-R)) but
may be useful in certain situations
– Burkitt lymphoma is a highly aggressive B-cell lymphoma and is curable and
treated with systemic and intrathecal chemotherapy
– Three types: endemic, sporadic, and immunodeciency associated
– Lymphoblastic lymphoma is usually of the T-cell phenotype and usually
affects the mediastinum; this is curable with aggressive chemotherapy
– Mantle-cell lymphoma is a B-cell lymphoma that has a moderately aggressive
clinical course, rarely curable, overall survival of 3–5years
– Patients with HIV infection have a signicantly increased incidence of lym-
phoma. The risk is increased approximately 1000-fold for Burkitt lymphoma
and 400-fold for aggressive lymphoma
T-Cell Lymphomas
• Rare in the head and neck region relative to B-cell lymphomas
• Associated with HTLV-1
• Extranodal NK/T-cell lymphoma, nasal type
– Nasal cavity, nasopharynx, and palate
– Diagnosis difcult due to diffuse thickening
– Localized disease treated with radiation, with or without chemotherapy
– The prognosis for those with disseminated disease is poor
– Common in East Asia and Latin America
• Anaplastic large-cell lymphoma (ALCL) tends to occur in young patients; longterm survival rate is approximately 70% with chemotherapy
• Angioimmunoblastic T-cell lymphoma is usually associated with immunodeciency. It tends to be aggressive with poor outcomes
Head andNeck Sarcoma
• Rare mesenchymal origin malignant tumor
Соседние файлы в папке Библиотека им академика М.И. Перельмана
